Hosted on MSN18d
Teva and Alvotech launch ustekinumab biosimilar injection in USa single-dose vial for subcutaneous injection at 45 mg/0.5 mL and a single-dose vial for intravenous infusion at 130 mg/26 mL. Ustekinumab is a human monoclonal antibody that targets the p40 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback